Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma
CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B...
Saved in:
Published in | Pathology oncology research Vol. 27; p. 602714 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media SA
23.02.2021
Frontiers Media S.A |
Subjects | |
Online Access | Get full text |
ISSN | 1532-2807 1219-4956 1532-2807 |
DOI | 10.3389/pore.2021.602714 |
Cover
Abstract | CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%;
p
= 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%;
p
= 0.032), less extensive necrosis (8.3 vs. 49.3%;
p
< 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months,
p
= 0.015).
In vitro
, iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA. |
---|---|
AbstractList | CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%;
p
= 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%;
p
= 0.032), less extensive necrosis (8.3 vs. 49.3%;
p
< 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months,
p
= 0.015).
In vitro
, iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA. CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%; p = 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%; p = 0.032), less extensive necrosis (8.3 vs. 49.3%; p < 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months, p = 0.015). In vitro, iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA.CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%; p = 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%; p = 0.032), less extensive necrosis (8.3 vs. 49.3%; p < 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months, p = 0.015). In vitro, iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA. CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%; p = 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%; p = 0.032), less extensive necrosis (8.3 vs. 49.3%; p < 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months, p = 0.015). In vitro, iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA. CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We retrospectively investigated 99 intrahepatic cholangiocarcinoma (iCCA) cases. Whole sections were used for immunohistochemical analysis for p62, and LC3B expression. Q-score was defined as the sum of the labeling intensity and proportion. The cut-off point for immunoreactivity was set. CUL4A was overexpressed in cell lines and autophagy reflux was compared after manipulation. The iCCA cases with CUL4A overexpression had significantly higher prevalence of intact activated autophagy (42.4 vs. 15.2%; = 0.003), which was significantly associated with advance tumor stage (34.1% vs. 15.4%; = 0.032), less extensive necrosis (8.3 vs. 49.3%; < 0.001), and shortened disease-free survival (mean, 19.6 vs. 65.5 months, = 0.015). , iCCA cells with CUL4A overexpression significantly increased LC3II level as compared to the cells under basal condition. Although both cell types showed intact autophagy with increased LC3II expression after bafilomycin A1 treatment, the accumulation of LC3II was higher in CUL4A-overexpressing cells. CUL4A overexpression increased the proliferation of cells as compared with control cells. After treatment with bafilomycin A1, proliferation was inhibited in both cell types, but the effects were more prominent in the cells overexpressing CUL4A. CUL4A promotes autophagy, and exhibits significantly higher autophagic flux which affects the proliferation of iCCA cells; these effects correlated with advance tumor stage and poor prognosis. Thus, targeting autophagy may be potentially therapeutic in iCCA. |
Author | You, Huey-Ling Huang, Wan-Ting Weng, Shao-Wen Eng, Hock-Liew Liu, Ting-Ting |
AuthorAffiliation | 1 Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan 3 Department of Medical Laboratory Science, I-Shou University, Kaohsiung , Taiwan 5 Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung , Taiwan 2 Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan 4 Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan |
AuthorAffiliation_xml | – name: 4 Department of Laboratory Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan – name: 5 Department of Medical Laboratory Sciences and Biotechnology, Fooyin University, Kaohsiung , Taiwan – name: 1 Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan – name: 2 Department of Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung , Taiwan – name: 3 Department of Medical Laboratory Science, I-Shou University, Kaohsiung , Taiwan |
Author_xml | – sequence: 1 givenname: Shao-Wen surname: Weng fullname: Weng, Shao-Wen – sequence: 2 givenname: Ting-Ting surname: Liu fullname: Liu, Ting-Ting – sequence: 3 givenname: Hock-Liew surname: Eng fullname: Eng, Hock-Liew – sequence: 4 givenname: Huey-Ling surname: You fullname: You, Huey-Ling – sequence: 5 givenname: Wan-Ting surname: Huang fullname: Huang, Wan-Ting |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34257560$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkUtr3DAURkVJaV7dd1UE3WTjqR62HpvCMPQRGOgQkmURsnw9VvBIrmQX5t_HZtKQdqULOnyce79LdBZiAIQ-ULLiXOnPQ0ywYoTRlSBM0vINuqAVZwVTRJ69ms_RZc6PhBAptHiHznnJKlkJcoF-racxDp3dH_Gut8eMLb6LPWAf8NgB3jxsy3VxB70docG7GBPepbgPMfuMY4tvw5hsB4MdvcObLvY27H10Njkf4sFeo7et7TO8f36v0MO3r_ebH8X25_fbzXpbOC7lWIBWDS15KWtBm1maOMWdrZXWlQIpWMNBtbamvGFAKtsq6ohual1aTktBNL9CX065w1QfoHGwaPVmSP5g09FE682_P8F3Zh__GMUEo4rMATfPASn-niCP5uCzg37eB-KUDasqWslSCzGjn_5DH-OUwryeWY6qCGNyMfr42uhF5e_lZ4CcAJdizgnaF4QSs5RrlnLNUq45lcufAHexl0o |
Cites_doi | 10.1002/1873-3468.12172 10.1172/JCI20039 10.1111/jcmm.12811 10.1016/j.bbrc.2016.10.114 10.1093/carcin/bgt063 10.1111/j.1582-4934.2009.00971.x 10.1038/cddis.2013.350 10.1158/1078-0432.CCR-11-1282 10.3892/ijmm.2018.3540 10.1016/j.devcel.2014.11.013 10.3892/or.2015.4324 10.1186/bcr2456 10.1038/nrd2974 10.18632/oncotarget.17554 10.1038/bjc.2014.355 10.1038/onc.2016.333 10.1098/rsob.130217 10.1371/journal.pone.0145388 10.1007/s10495-015-1176-3 10.1158/0008-5472.CAN-13-2182 10.1158/0008-5472.CAN-04-2598 10.1126/science.1193497 10.1073/pnas.2436255100 10.1371/journal.pone.0074407 10.1186/s12885-017-3389-z 10.4081/ejh.2015.2481 10.1007/s00109-012-0885-0 10.4161/auto.26398 10.1056/NEJMc1303158 10.1038/s41388-017-0046-6 10.1053/jhep.2002.33683 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Weng, Liu, Eng, You and Huang. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2021 Weng, Liu, Eng, You and Huang. 2021 Weng, Liu, Eng, You and Huang |
Copyright_xml | – notice: Copyright © 2021 Weng, Liu, Eng, You and Huang. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2021 Weng, Liu, Eng, You and Huang. 2021 Weng, Liu, Eng, You and Huang |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.3389/pore.2021.602714 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25. Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Central Nursing & Allied Health Premium ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Nursing & Allied Health Source (Alumni) ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Weng et al |
EISSN | 1532-2807 |
ExternalDocumentID | PMC8262180 34257560 10_3389_pore_2021_602714 |
Genre | Journal Article |
GeographicLocations | United States--US Switzerland Japan |
GeographicLocations_xml | – name: Switzerland – name: United States--US – name: Japan |
GrantInformation_xml | – fundername: Ministry of Science, Technology and Research |
GroupedDBID | --- .VR 06C 06D 0R~ 123 1N0 203 29O 29~ 2J2 2KG 2KM 2LR 2~H 30V 4.4 408 40D 40E 53G 5VS 67N 67Z 6NX 7RV 7X7 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X 9T4 AAAVM AABHQ AAJKR AARTL AATVU AAWCG AAYIU AAYQN AAYXX ABDZT ABFTV ABJNI ABJOX ABKCH ABMNI ABNWP ABPLI ABQBU ABTEG ABTHY ABTMW ABUWG ABXPI ACGFS ACHXU ACKNC ACMLO ACOKC ACOMO ACPRK ACSNA ADBBV ADHHG ADHIR ADKPE ADRFC ADURQ ADYFF ADZKW AEGAL AEGNC AEJHL AEJRE AENEX AEOHA AEPYU AETLH AEXYK AFBBN AFKRA AFRAH AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHYZX AIIXL AILAN AITGF AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMYQR ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BENPR CCPQU CITATION CS3 CSCUP DU5 E3Z EBD EBS EIOEI EMOBN ESBYG EX3 F5P FDB FERAY FFXSO FNLPD FRRFC FWDCC FYUFA G-Q G-Y G-Z GGRSB GJIRD GNWQR GQ7 GROUPED_DOAJ HF~ HMCUK HMJXF HRMNR HZ~ IJ- IXC IXD I~X I~Z J-C J0Z JBSCW KOV KPH MA- NAPCQ NB0 NQ- NQJWS O93 O9I O9J OK1 PF0 PGMZT PHGZM PHGZT PIMPY PROAC QOK QOR QOS R89 R9I RPM RSV S16 S27 S3A S3B SAP SBL SDH SHX SISQX SOJ SPISZ SSXJD STPWE SV3 SZN T13 TSG TSK TSV TUC U2A UG4 UKHRP UOJIU UTJUX VC2 W48 WK8 WOW YLTOR Z45 ZMTXR ZOVNA ~A9 --K -Y2 0VY 1B1 1RT 1~5 2JY 2VQ 2WC 4G. 7-5 88E AAEDT AAFWJ AAIAL AALRI AANXM AAQFI AAQXK AARHV AAXUO AAYTO AAYZH ABMAC ABMOR ABWVN ACRPL ADMUD ADNMO ADYPR AEBTG AFGCZ AFLOW AFPKN AGJBK AHSBF AITUG AJBLW BDATZ BGNMA BKEYQ BPHCQ BVXVI CAG CGR COF CUY CVF ECM EIF EJD EN4 EO8 EO9 EP2 FEDTE FGOYB FINBP FSGXE H13 HVGLF IHE M1P M41 M4Y NPM NU0 O9- P6G PQQKQ PSQYO R2- RHV RIG ROL RPZ S1Z SDG SSZ TR2 UHS UZXMN VFIZW 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PPXIY PQEST PQUKI 7X8 PUEGO ~HD 5PM |
ID | FETCH-LOGICAL-c377t-e98d14347b61d1530c83cab89958e762d3e8fab13d2e05af81c09db94a3146093 |
IEDL.DBID | 7X7 |
ISSN | 1532-2807 1219-4956 |
IngestDate | Thu Aug 21 13:47:55 EDT 2025 Sun Sep 28 10:24:28 EDT 2025 Mon Jul 14 09:25:45 EDT 2025 Thu Apr 03 07:06:44 EDT 2025 Tue Jul 01 02:53:21 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | CUL4A LC3II autophagy prognosis intrahepatic cholangiocarcinoma |
Language | English |
License | Copyright © 2021 Weng, Liu, Eng, You and Huang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c377t-e98d14347b61d1530c83cab89958e762d3e8fab13d2e05af81c09db94a3146093 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 These authors have contributed equally to this work Edited by: László Kopper, Semmelweis University, Hungary |
OpenAccessLink | https://www.proquest.com/docview/2575802279?pq-origsite=%requestingapplication% |
PMID | 34257560 |
PQID | 2575802279 |
PQPubID | 5225552 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262180 proquest_miscellaneous_2551574966 proquest_journals_2575802279 pubmed_primary_34257560 crossref_primary_10_3389_pore_2021_602714 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-23 |
PublicationDateYYYYMMDD | 2021-02-23 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-23 day: 23 |
PublicationDecade | 2020 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Dordrecht |
PublicationTitle | Pathology oncology research |
PublicationTitleAlternate | Pathol Oncol Res |
PublicationYear | 2021 |
Publisher | Frontiers Media SA Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media SA – name: Frontiers Media S.A |
References | Wang (B8) 2014; 74 Lazova (B23) 2012; 18 Nag (B2) 2004; 64 Singh (B11) 2018; 37 Li (B19) 2013; 34 Niklaus (B18) 2017; 8 Yu (B28) 2018; 41 Hung (B30) 2015; 34 Chen (B3) 1998; 58 Sui (B31) 2013; 4 Choi (B12) 2013; 368 Schlafli (B15) 2015; 59 Peng (B25) 2013; 8 Liu (B9) 2015; 10 Huang (B10) 2017; 17 Melchor (B7) 2009; 11 Ren (B6) 2012; 90 Peng (B24) 2013; 9 Hung (B5) 2011; 15 Antonioli (B14) 2014; 31 Rabinowitz (B13) 2010; 330 Yue (B22) 2003; 100 Han (B27) 2016; 480 Copeland (B32) 2009; 8 Mowers (B26) 2017; 36 Hung (B29) 2016; 20 Sharma (B1) 2014; 4 Liu (B17) 2014; 111 Kim (B20) 2016; 590 Falasca (B16) 2015; 20 Hsieh (B33) 2016; 6 Qu (B21) 2003; 112 Yasui (B4) 2002; 35 |
References_xml | – volume: 590 start-page: 1365 year: 2016 ident: B20 article-title: Uncoordinated 51-like kinase 2 signaling pathway regulates epithelial-mesenchymal transition in A549 lung cancer cells publication-title: FEBS Lett. doi: 10.1002/1873-3468.12172 – volume: 112 start-page: 1809 year: 2003 ident: B21 article-title: Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene publication-title: J. Clin. Invest. doi: 10.1172/JCI20039 – volume: 20 start-page: 1295 year: 2016 ident: B29 article-title: Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.12811 – volume: 480 start-page: 675 year: 2016 ident: B27 article-title: CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2016.10.114 – volume: 34 start-page: 1343 year: 2013 ident: B19 article-title: Autophagy promotes hepatocellular carcinoma cell invasion through activation of epithelial-mesenchymal transition publication-title: Carcinogenesis doi: 10.1093/carcin/bgt063 – volume: 15 start-page: 350 year: 2011 ident: B5 article-title: Cul4A is an oncogene in malignant pleural mesothelioma publication-title: J. Cell Mol. Med. doi: 10.1111/j.1582-4934.2009.00971.x – volume: 4 start-page: e838 year: 2013 ident: B31 article-title: Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment publication-title: Cell Death Dis. doi: 10.1038/cddis.2013.350 – volume: 18 start-page: 370 year: 2012 ident: B23 article-title: Punctate LC3B expression is a common feature of solid tumors and associated with proliferation, metastasis, and poor outcome publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-11-1282 – volume: 41 start-page: 3147 year: 2018 ident: B28 article-title: miR377 targets CUL4A and regulates metastatic capability in ovarian cancer publication-title: Int. J. Mol. Med. doi: 10.3892/ijmm.2018.3540 – volume: 31 start-page: 734 year: 2014 ident: B14 article-title: AMBRA1 interplay with cullin E3 ubiquitin ligases regulates autophagy dynamics publication-title: Dev. Cell doi: 10.1016/j.devcel.2014.11.013 – volume: 34 start-page: 3187 year: 2015 ident: B30 article-title: Knockdown of Cul4A increases chemosensitivity to gemcitabine through upregulation of TGFBI in lung cancer cells publication-title: Oncol. Rep. doi: 10.3892/or.2015.4324 – volume: 11 start-page: R86 year: 2009 ident: B7 article-title: Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes publication-title: Breast Cancer Res. doi: 10.1186/bcr2456 – volume: 8 start-page: 724 year: 2009 ident: B32 article-title: Protein methyltransferases as a target class for drug discovery publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2974 – volume: 8 start-page: 54604 year: 2017 ident: B18 article-title: Expression analysis of LC3B and p62 indicates intact activated autophagy is associated with an unfavorable prognosis in colon cancer publication-title: Oncotarget doi: 10.18632/oncotarget.17554 – volume: 58 start-page: 3677 year: 1998 ident: B3 article-title: The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers publication-title: Cancer Res. – volume: 111 start-page: 944 year: 2014 ident: B17 article-title: Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma publication-title: Br. J. Cancer doi: 10.1038/bjc.2014.355 – volume: 36 start-page: 1619 year: 2017 ident: B26 article-title: Autophagy in cancer metastasis publication-title: Oncogene doi: 10.1038/onc.2016.333 – volume: 4 start-page: 130217 year: 2014 ident: B1 article-title: CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases publication-title: Open Biol. doi: 10.1098/rsob.130217 – volume: 10 start-page: e0145388 year: 2015 ident: B9 article-title: Recurrent amplification at 13q34 targets at CUL4A, IRS2, and TFDP1 as an independent adverse prognosticator in intrahepatic cholangiocarcinoma publication-title: Plos One. doi: 10.1371/journal.pone.0145388 – volume: 20 start-page: 1577 year: 2015 ident: B16 article-title: AMBRA1 and SQSTM1 expression pattern in prostate cancer publication-title: Apoptosis doi: 10.1007/s10495-015-1176-3 – volume: 74 start-page: 520 year: 2014 ident: B8 article-title: CUL4A induces epithelial-mesenchymal transition and promotes cancer metastasis by regulating ZEB1 expression publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-2182 – volume: 64 start-page: 8152 year: 2004 ident: B2 article-title: Cul4A physically associates with MDM2 and participates in the proteolysis of p53 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-04-2598 – volume: 6 start-page: 1661 year: 2016 ident: B33 article-title: EZH2 inhibitors transcriptionally upregulate cytotoxic autophagy and cytoprotective unfolded protein response in human colorectal cancer cells publication-title: Am. J. Cancer Res. – volume: 330 start-page: 1344 year: 2010 ident: B13 article-title: Autophagy and metabolism publication-title: Science doi: 10.1126/science.1193497 – volume: 100 start-page: 15077 year: 2003 ident: B22 article-title: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor publication-title: Proc. Natl. Acad. Sci. USA. doi: 10.1073/pnas.2436255100 – volume: 8 start-page: e74407 year: 2013 ident: B25 article-title: Promoting colonization in metastatic HCC cells by modulation of autophagy publication-title: PloS One doi: 10.1371/journal.pone.0074407 – volume: 17 start-page: 395 year: 2017 ident: B10 article-title: CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma publication-title: BMC Cancer. doi: 10.1186/s12885-017-3389-z – volume: 59 start-page: 2481 year: 2015 ident: B15 article-title: Reliable LC3 and p62 autophagy marker detection in formalin fixed paraffin embedded human tissue by immunohistochemistry publication-title: Eur. J. Histochem. doi: 10.4081/ejh.2015.2481 – volume: 90 start-page: 1121 year: 2012 ident: B6 article-title: Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer publication-title: J. Mol. Med. doi: 10.1007/s00109-012-0885-0 – volume: 9 start-page: 2056 year: 2013 ident: B24 article-title: Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells publication-title: Autophagy doi: 10.4161/auto.26398 – volume: 368 start-page: 651 year: 2013 ident: B12 article-title: Autophagy in human health and disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMc1303158 – volume: 37 start-page: 1142 year: 2018 ident: B11 article-title: Dual role of autophagy in hallmarks of cancer publication-title: Oncogene doi: 10.1038/s41388-017-0046-6 – volume: 35 start-page: 1476 year: 2002 ident: B4 article-title: TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas publication-title: Hepatology doi: 10.1053/jhep.2002.33683 |
SSID | ssj0007696 |
Score | 2.234861 |
Snippet | CUL4A regulate the termination of autophagy in a physical process. However, the relationship between CUL4A and autophagy in cancer is unclear. We... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 602714 |
SubjectTerms | Antibodies Autophagy Bile Duct Neoplasms - metabolism Bile Duct Neoplasms - mortality Bile Duct Neoplasms - pathology Biomarkers, Tumor - metabolism Cancer Cholangiocarcinoma Cholangiocarcinoma - metabolism Cholangiocarcinoma - mortality Cholangiocarcinoma - pathology Cloning Cullin Proteins - metabolism Female Follow-Up Studies Gene expression Humans Male Medical prognosis Metabolism Metastasis Middle Aged Prognosis Prostate Proteins Retrospective Studies Society Journal Archive Survival analysis Survival Rate Tumor Cells, Cultured Tumorigenesis |
Title | Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34257560 https://www.proquest.com/docview/2575802279 https://www.proquest.com/docview/2551574966 https://pubmed.ncbi.nlm.nih.gov/PMC8262180 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZtAqWX0vQVN8miQi89qLEiybJPZbMkpKUJS-jCXorRa5OF1Nru45B_nxnZu-m20LOFZc9IM9-nGc0Q8lHbYH0hDFM8eCY9lrwNlWLKuGBM0Goi8e7w5VVxMZLfxmrcHbgturTKtU1MhtpHh2fkx7C0VJnq3X2Z_WbYNQqjq10LjadklwMSwdYNerwhXEDRU38uDruSIRFow5RAyqrjGdaIBOLPPxdAzLjcdkv_YM2_Uyb_8EHnL8mLDjzSfqvtPfIkNK_Is8suPP6a_OyvsE6Aubmnwztzv6CGXse7QKcNBZxHB6Pvss9S-lvwdBjjnA7nETPtpgsaJ_QrTnobMMfa0QGS3uZmCr5uDm-Pv8wbMjo_-zG4YF3_BOaE1ksWqtIDHJLaFtyDZctdKZyxwLBUGcAIehHKibFc-JOQKzMpucsrbytpBNjPvBJvyU4Tm7BPKPfWuBMnfRHA5Ve2Kk2Ra-ektAAhhMrIp7X46llbJqMGeoGirlHUNYq6bkWdkcO1fOtuwyzqR_Vm5MPmMSx1jF-YJsQVjgHwpSUQtIy8a9WxmUyg7QH0lhG9pajNACyjvf2kmd6mctpAsADn5O___1kH5Dn-Q7rNLg7JznK-CkeAR5a2lxZdj-yenl0Nr3uJ1ffSsdED6bbjUw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VRQIuiHddCiwSHDgs9WPttQ9VFQWqhCZVhBopF2T2lTZSsdM8hPKn-hs7Y8eBgMSt51157dl5fJ9ndhbgvdRO2yRSPA6c5cJSy1uXxTxWxinlZDwWdHa4f5Z0huLrKB7twE1zFobKKhufWDlqWxr6R36IqhWnVb-74-k1p1ujKLvaXKFRq8WpW_1CyjY_6n7G_f0Qhidfztsdvr5VgJtIygV3WWoRJAipk8CivfsmjYzSyDvi1KFrsJFLx0oHkQ2dH6txGhg_szoTKkKvUjVfQpd_T1CKEe1HjjYEz5dJdR9YgF6AE_Go06JIArPDKfWkDDGgfkqQCAZiOwz-g23_LtH8I-adPIZHa7DKWrV2PYEdVzyF-_11Ov4ZfG8tqS-BulixwZVazZli38orxyYFQ1zJ2sOeaPGq3M5ZNijLGRvMSqrsm8xZOWZdWvTSUU23YW0i2cXFBGPrDJ9e_lTPYXgnkn0Bu0VZuD1ggdXKhEbYxCHEyHSWqsSXxgihEbJEsQcfG_Hl07otR450hkSdk6hzEnVei9qDg0a--dpA5_lvdfLg3WYYTYvyJapw5ZLmINiTAgmhBy_r7dgsFpGvQ7TogdzaqM0Eatu9PVJMLqv23UjoEFf5-_9_rbfwoHPe7-W97tnpK3hI31OdpI8OYHcxW7rXiIUW-k2lgAx-3LXG3wLaZhvC |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VRaq4IN64FFgkOHAwsb1rr31AKEqJGvpQhIiUCzL7chup2CEPofw1fh0zfgQCEreed-W1Z2dnvs8zOwPwSmqnbcKVH4fO-sJSyVuXxX6sjFPKybgQdHf4_CI5mYiP03i6Bz-7uzCUVtnZxNpQ28rQP_Ieqlac1vXuekWbFjE-Hr6ff_epgxRFWrt2Go2KnLrND6Rvy3ejY9zr11E0_PB5cOK3HQZ8w6Vc-S5LLQIGIXUSWjz7gUm5URo5SJw6NBOWu7RQOuQ2ckGsijQ0QWZ1JhRHC1MXYkLzf0tyIahthJxuyV4gk7o3WIgWwScS0oRIkRBmvTnVp4zQub5NkBSGYtcl_oNz_07X_MP_De_CnRa4sn6jafdgz5X34eC8Dc0_gC_9NdUoUJcbNr5WmyVT7FN17disZIgx2WByJvp-nXrnLBtX1YKNFxVl-c2WrCrYiBa9cpTfbdiACHd5OUM_u8CnV9_UQ5jciGQfwX5Zle4JsNBqZSIjbOIQbmQ6S1USSGOE0AhfeOzBm058-bwp0ZEjtSFR5yTqnESdN6L24KiTb94e1mX-W7U8eLkdxmNGsRNVumpNcxD4SYHk0IPHzXZsF-Nk9xA5eiB3Nmo7gUp4746Us6u6lDeSO8RYweH_X-sFHKCu52eji9OncJs-p75Uz49gf7VYu2cIi1b6ea1_DL7etML_AuZrH_U |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Autophagy+Plays+a+Role+in+the+CUL4A-Related+Poor+Prognosis+of+Intrahepatic+Cholangiocarcinoma&rft.jtitle=Pathology+oncology+research&rft.au=Weng%2C+Shao-Wen&rft.au=Liu%2C+Ting-Ting&rft.au=Eng%2C+Hock-Liew&rft.au=You%2C+Huey-Ling&rft.date=2021-02-23&rft.pub=Frontiers+Media+S.A&rft.issn=1219-4956&rft.eissn=1532-2807&rft.volume=27&rft_id=info:doi/10.3389%2Fpore.2021.602714&rft_id=info%3Apmid%2F34257560&rft.externalDocID=PMC8262180 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1532-2807&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1532-2807&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1532-2807&client=summon |